Comments

2022/10/11

Comments on the patent subject matter eligibility guidance（Addressed to USPTO ）

2022/6/9

Comments on “the Implementation Regulation of the PRC Drug Administration Law (Draft for Public Opinions)（in Chinese）” (Addressed to National Medical Products Administration)

2022/5/13

Comments on “Proposal for a Regulation on harmonised rules on fair access to and use of data (Data Act)” (Addressed to European Commission)

2022/3/30

Comments on “Intellectual Property Strategic Program 2022”(Addressed to the Intellectual Property Strategy Headquarters，Cabinet Office)

2022/2/2

Comments on the amendment bill of Thailand Patent Act (Addressed to Department of Intellectual Property, Ministry of Commerce, Thailand)

2022/1/7

Comments on “Open consultation : AI and IP: copyright and patents” (Addressed to the Intellectual Property Office, the United Kingdom)

2022/1/5

Comments on "Draft guidelines on disclosure and governance of strategies for investment and utilization of IP and Intangible Assets（Intellectual Property・Intangible Assets Governance Guidelines）” (Addressed to the Intellectual Property Strategy Headquarters，Cabinet Office)